Pathology | bioRxiv
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
Related Articles
Lonza seeks deals as it exits health and ingredients to focus on contract development
Swiss contract drugmaker Lonza plans to simplify its structure and exit its capsules and health ingredients (CHI) business after a decline in demand for pharmaceutical…
Global health researcher Madhukar Pai believes scientific innovations must reach everyone
Working toward a more diverse, inclusive, and equitable future for global health with Dr. Pai.
As Rural America Grows More Diverse, Language Access Is Slow To Take Hold – KFF Health News
The share of people who are Hispanic or Latino has grown to a little more than a quarter of the population in Elko, Nevada, a…
AI versus AI: The emerging arms race over health insurance denials
As health insurers use AI to deny more claims, startups are turning to AI to make it easier to appeal denials, which often go uncontested.
Inequalities in uptake of childhood vaccination in England, 2019-23: longitudinal study
Objective To quantify changes in inequalities in uptake of childhood vaccination during a period of steadily declining overall childhood vaccination rates in England. Design Longitudinal…
The Hidden Dangers of AI Confidence Scores in Healthcare – MedCity News
AI can serve as an invaluable tool, but blindly trusting “confidence scores” creates serious risks. Here are some better alternatives.
Health-care workers are under attack. We must do more to ensure their safety – Healthy Debate
Every day health-care workers experience a spectrum of abusive behaviour while providing care. More needs to be done to stop it.
Bedaquiline Monotherapy for Multibacillary Leprosy | NEJM
Standard multidrug therapy for leprosy may be associated with severe side effects, which add to the stigma and discrimination that affect persons with the disease.…
Register – The Lancet Diabetes & Endocrinology Commission Launch Event – Zoom
Please join us for the global launch of The Lancet Diabetes & Endocrinology Commission on Diagnostic Criteria of Clinical O…
Europe allows Novo to include reduction of kidney disease in Ozempic label
The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the label of its diabetes…